Crescenta Biosciences Inc.

Crescenta Biosciences Inc. is a small molecule drug discovery company focused on developing novel therapeutic approaches for diseases related to fatty acid metabolism. Crescenta’s discovery platform is based on a new concept that allows for the manipulation of biological functions associated with “fatty acid interacting proteins” in such a way to correct metabolic imbalance, thus providing broad therapeutic opportunities. By applying this unique platform, the company has assembled a portfolio of first-in-class drug candidates for the treatment of diseases with major unmet medical needs, particularly those related to metabolism and aging. Crescenta’s goal is to advance its pipeline into clinical development and commercialization.